Pfizer global commercial access partnerships director. Addressing challenges in prevention, personnel, facilities, and treatment can have a sweeping effect on the health of a population.

Pfizer’s Centers for Therapeutic Innovation and other partnership initiatives champion emerging science and help stakeholders realize the potential of their innovations. Successful drug ...

we are committed to accelerating the availability of global innovations while fostering partnerships with governments, healthcare providers, and key stakeholders,” Serhat Yalcinkaya, Pfizer Gulf ...

Pfizer's innovation in R&D, including AI partnerships and new drug approvals, promises long-term market cap growth and a competitive edge. Defensive stocks like Pfizer are attractive amid market ...

With the company’s Q1 2025 results on Tuesday, Pfizer (NYSE:PFE) indicated plans to explore acquisitions or partnerships to add cardiometabolic assets, including weight loss therapies ...

Pfizer (NYSE:PFE) is overhauling its cardiometabolic ... antagonist and pursuing external opportunities that could include partnerships or acquisitions. That strategic pivot comes as shares ...

Pharmaceutical and biotechnology company Pfizer marks 70 years of dedication to its mission of advancing patient health in ...

With the Trump administration imposing sweeping tariffs, fears of a global recession ... sales of Pfizer’s COVID products, Comirnaty and Paxlovid, which it developed in partnership with BioNTech ...

Meanwhile, a new partnership could address global inequities in vaccine access ... For its international phase 3 trial, Pfizer recruited nearly 44,000 subjects on five continents to represent ...

(NASDAQ:GH) on Thursday announced a strategic collaboration with Pfizer ... for its global clinical trials, which include China cohorts. In July 2022, Guardant announced a strategic partnership ...